post-add

Articles for Finance

Q4 Result: Indraprastha Medical Corporation Net Profit Jumps By 30% To Rs 19.84 Cr

Indraprastha Medical Corporation on Tuesday announced its January-March quarter results, the healthcare provider has clocked a Profit After Tax (PAT) of Rs 19.84 crores in quarter four of the financial year 2023, registering a jump of 30.5 per cent year on year against Rs 15.20 crores registered in the same quarter in FY2022

Read More
Divi's Labs PAT Slumps By 64.2% In Q4FY23

Divi's Laboratories on Saturday announced its earnings for the fourth quarter and full year FY23. The company posted a drop in its net profits by 64.2 per cent year on year (YoY) in the March quarter to Rs 320 crores down from 894 crores in the same quarter of the previous year

Read More
Gland Pharma's Net Profits Tank By 72.2% YoY In Q4FY23

Gland Pharma on Thursday announced its earnings for the fourth quarter and full year FY23. The company's revenue recorded a slump in Q4FY23 by 29.4 per cent year on year (YoY) to be recorded at Rs 824 crore and by 16.6 per cent for FY23 to Rs 3,856 crore compared with Rs 1,168 crore in Q4FY22 and Rs 4,624 in FY22 respectively

Read More
Q4 Results: Zydus Lifesciences Revenues Soar By Over 31%, PAT At 296 Cr

Zydus Lifesciences on Thursday announced its earnings for the fourth quarter and full year FY23. The company's consolidated revenue recorded a major jump in Q4FY23 by 31.7 per cent year on year (YoY) to Rs 5,010 crore and by 14.1 per cent for FY23 to Rs 17,237 crore compared with Rs 3,805 crores in Q4FY22 and Rs 15,109 in FY22 respectively

Read More
GSK Pharma's Net Profits Rise By Over 9%, Revenue Falls By 1.5% YoY In Q4FY23

GlaxoSmithKline Pharmaceuticals on Wednesday announced its earnings for the fourth quarter and full year FY23. The company's consolidated revenue recorded a slight fall in Q4FY23 by 1.5 per cent year on year (YoY) to Rs 828 crore and by 0.03 per cent for FY23 to Rs 3,352 crore compared with Rs 825 crores in Q4FY22 and Rs 3,353 in FY22 respectively

Read More
Eris Lifesciences PAT Drops By 23% YoY In Q4FY23

Eris Lifesciences, an Indian branded formulations manufacturing company on Wednesday announced its earnings for the fourth quarter and full year FY23. The company's revenue for Q4FY23 grew by 32 per cent year on year (YoY) to Rs 402 crore and for FY23 the revenues grew by 25 per cent YoY to Rs 1,685 crores

Read More
Pfizer Plans To Raise $31 Bn To Fund Seagen Acquisition

Pfizer Inc said on Tuesday it plans to raise USD 31 billion from a debt offering to finance its proposed acquisition of Seagen Inc

Read More
Max Healthcare's PAT Nearly Doubles In Q4FY23, Records Revenue At Rs 1,637 Cr

Max Healthcare, the Indian healthcare provider headquartered in New Delhi has reported its earnings for the quarter that ended on 31st March 2023, the hospital chain has registered a rise of 26 per cent year on year in its consolidated revenue to be recorded at Rs 1,637 crores in the Quarter Four of Financial Year 2023(Q4FY23) up from Rs 1,296 crores in the corresponding quarter last year

Read More

Subscribe to our newsletter to get updates on our latest news